[1]
|
Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
Frontiers in Pharmacology,
2021
DOI:10.3389/fphar.2021.700587
|
|
|
[2]
|
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer’s disease
International Journal of Pharmaceutics,
2020
DOI:10.1016/j.ijpharm.2020.120011
|
|
|
[3]
|
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
eNeurologicalSci,
2018
DOI:10.1016/j.ensci.2018.09.002
|
|
|
[4]
|
Metabolomic‐guided discovery of Alzheimer's disease biomarkers from body fluid
Journal of Neuroscience Research,
2017
DOI:10.1002/jnr.24048
|
|
|
[5]
|
Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid
Journal of Neuroscience Research,
2017
DOI:10.1002/jnr.24048
|
|
|
[6]
|
Detection of mild cognitive impairment using a counterpropagation network based system. An e-health solution
2015 International Workshop on Computational Intelligence for Multimedia Understanding (IWCIM),
2015
DOI:10.1109/IWCIM.2015.7347094
|
|
|
[7]
|
PET Radiotracers for Imaging P-glycoprotein: The Challenge for Early Diagnosis in AD
ChemMedChem,
2014
DOI:10.1002/cmdc.201300362
|
|
|
[8]
|
Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips
The Analyst,
2014
DOI:10.1039/C4AN01296H
|
|
|
[9]
|
PET Radiotracers for Imaging P‐glycoprotein: The Challenge for Early Diagnosis in AD
ChemMedChem,
2014
DOI:10.1002/cmdc.201300362
|
|
|
[10]
|
Advances in Alzheimer’s disease (AAD): Standing firm at its first anniversary
Advances in Alzheimer's Disease,
2013
DOI:10.4236/aad.2013.22006
|
|
|